ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Acute Kidney Injury Therapeutics Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-9L14504
Home | Market Reports | Health| Health Conditions
Global Acute Kidney Injury Therapeutics Market Research Report 2023
BUY CHAPTERS

Global Acute Kidney Injury Therapeutics Market Research Report 2025

Code: QYRE-Auto-9L14504
Report
July 2025
Pages:72
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Quark Pharmaceuticals
Alloksys
Angio Biomedica Corporation
Stealth Bio Therapeutics
Silver Creek Pharmaceuticals
AM Pharma Holding
Ischemix Inc
Biomerieux
A1M Pharma

Acute Kidney Injury Therapeutics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Acute Kidney Injury Therapeutics Market

Acute Kidney Injury Therapeutics Market

The global market for Acute Kidney Injury Therapeutics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Acute kidney injury therapeutics is the cure to the acute kidney injury that is a group of clinical syndromes that refers to sudden (within 1-7d) and sustained (> 24h) sudden declines in renal function. It is defined as an increase in serum creatinine (SCr) of at least 0.5mg / dl 1 and manifested as nitrogen. Plasmaemia, water-electrolyte and acid-base balance and systemic symptoms can be accompanied by oliguria (<400ml / 24h or 17ml / h) or anuria (<100ml / 24h).
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Acute Kidney Injury Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acute Kidney Injury Therapeutics.
The Acute Kidney Injury Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Acute Kidney Injury Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Acute Kidney Injury Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Acute Kidney Injury Therapeutics Market Report

Report Metric Details
Report Name Acute Kidney Injury Therapeutics Market
CAGR 5%
Segment by Type
  • Non-drug
  • Drugs
Segment by Application
  • Hospitals
  • Clinic
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Quark Pharmaceuticals, Alloksys, Angio Biomedica Corporation, Stealth Bio Therapeutics, Silver Creek Pharmaceuticals, AM Pharma Holding, Ischemix, Biomerieux, A1M Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Acute Kidney Injury Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Acute Kidney Injury Therapeutics Market report?

Ans: The main players in the Acute Kidney Injury Therapeutics Market are Quark Pharmaceuticals, Alloksys, Angio Biomedica Corporation, Stealth Bio Therapeutics, Silver Creek Pharmaceuticals, AM Pharma Holding, Ischemix, Biomerieux, A1M Pharma

What are the Application segmentation covered in the Acute Kidney Injury Therapeutics Market report?

Ans: The Applications covered in the Acute Kidney Injury Therapeutics Market report are Hospitals, Clinic, Other

What are the Type segmentation covered in the Acute Kidney Injury Therapeutics Market report?

Ans: The Types covered in the Acute Kidney Injury Therapeutics Market report are Non-drug, Drugs

Recommended Reports

Kidney & Renal Diseases

Urinary & Bladder Drugs

Therapy & Rare Conditions

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acute Kidney Injury Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Non-drug
1.2.3 Drugs
1.3 Market by Application
1.3.1 Global Acute Kidney Injury Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Acute Kidney Injury Therapeutics Market Perspective (2020-2031)
2.2 Global Acute Kidney Injury Therapeutics Growth Trends by Region
2.2.1 Global Acute Kidney Injury Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Acute Kidney Injury Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Acute Kidney Injury Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Acute Kidney Injury Therapeutics Market Dynamics
2.3.1 Acute Kidney Injury Therapeutics Industry Trends
2.3.2 Acute Kidney Injury Therapeutics Market Drivers
2.3.3 Acute Kidney Injury Therapeutics Market Challenges
2.3.4 Acute Kidney Injury Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Acute Kidney Injury Therapeutics Players by Revenue
3.1.1 Global Top Acute Kidney Injury Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Acute Kidney Injury Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Acute Kidney Injury Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Acute Kidney Injury Therapeutics Revenue
3.4 Global Acute Kidney Injury Therapeutics Market Concentration Ratio
3.4.1 Global Acute Kidney Injury Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acute Kidney Injury Therapeutics Revenue in 2024
3.5 Global Key Players of Acute Kidney Injury Therapeutics Head office and Area Served
3.6 Global Key Players of Acute Kidney Injury Therapeutics, Product and Application
3.7 Global Key Players of Acute Kidney Injury Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Acute Kidney Injury Therapeutics Breakdown Data by Type
4.1 Global Acute Kidney Injury Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Acute Kidney Injury Therapeutics Forecasted Market Size by Type (2026-2031)
5 Acute Kidney Injury Therapeutics Breakdown Data by Application
5.1 Global Acute Kidney Injury Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Acute Kidney Injury Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Acute Kidney Injury Therapeutics Market Size (2020-2031)
6.2 North America Acute Kidney Injury Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Acute Kidney Injury Therapeutics Market Size by Country (2020-2025)
6.4 North America Acute Kidney Injury Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Acute Kidney Injury Therapeutics Market Size (2020-2031)
7.2 Europe Acute Kidney Injury Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Acute Kidney Injury Therapeutics Market Size by Country (2020-2025)
7.4 Europe Acute Kidney Injury Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Acute Kidney Injury Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Acute Kidney Injury Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Acute Kidney Injury Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Acute Kidney Injury Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Acute Kidney Injury Therapeutics Market Size (2020-2031)
9.2 Latin America Acute Kidney Injury Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Acute Kidney Injury Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Acute Kidney Injury Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Acute Kidney Injury Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Acute Kidney Injury Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Acute Kidney Injury Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Acute Kidney Injury Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Quark Pharmaceuticals
11.1.1 Quark Pharmaceuticals Company Details
11.1.2 Quark Pharmaceuticals Business Overview
11.1.3 Quark Pharmaceuticals Acute Kidney Injury Therapeutics Introduction
11.1.4 Quark Pharmaceuticals Revenue in Acute Kidney Injury Therapeutics Business (2020-2025)
11.1.5 Quark Pharmaceuticals Recent Development
11.2 Alloksys
11.2.1 Alloksys Company Details
11.2.2 Alloksys Business Overview
11.2.3 Alloksys Acute Kidney Injury Therapeutics Introduction
11.2.4 Alloksys Revenue in Acute Kidney Injury Therapeutics Business (2020-2025)
11.2.5 Alloksys Recent Development
11.3 Angio Biomedica Corporation
11.3.1 Angio Biomedica Corporation Company Details
11.3.2 Angio Biomedica Corporation Business Overview
11.3.3 Angio Biomedica Corporation Acute Kidney Injury Therapeutics Introduction
11.3.4 Angio Biomedica Corporation Revenue in Acute Kidney Injury Therapeutics Business (2020-2025)
11.3.5 Angio Biomedica Corporation Recent Development
11.4 Stealth Bio Therapeutics
11.4.1 Stealth Bio Therapeutics Company Details
11.4.2 Stealth Bio Therapeutics Business Overview
11.4.3 Stealth Bio Therapeutics Acute Kidney Injury Therapeutics Introduction
11.4.4 Stealth Bio Therapeutics Revenue in Acute Kidney Injury Therapeutics Business (2020-2025)
11.4.5 Stealth Bio Therapeutics Recent Development
11.5 Silver Creek Pharmaceuticals
11.5.1 Silver Creek Pharmaceuticals Company Details
11.5.2 Silver Creek Pharmaceuticals Business Overview
11.5.3 Silver Creek Pharmaceuticals Acute Kidney Injury Therapeutics Introduction
11.5.4 Silver Creek Pharmaceuticals Revenue in Acute Kidney Injury Therapeutics Business (2020-2025)
11.5.5 Silver Creek Pharmaceuticals Recent Development
11.6 AM Pharma Holding
11.6.1 AM Pharma Holding Company Details
11.6.2 AM Pharma Holding Business Overview
11.6.3 AM Pharma Holding Acute Kidney Injury Therapeutics Introduction
11.6.4 AM Pharma Holding Revenue in Acute Kidney Injury Therapeutics Business (2020-2025)
11.6.5 AM Pharma Holding Recent Development
11.7 Ischemix
11.7.1 Ischemix Company Details
11.7.2 Ischemix Business Overview
11.7.3 Ischemix Acute Kidney Injury Therapeutics Introduction
11.7.4 Ischemix Revenue in Acute Kidney Injury Therapeutics Business (2020-2025)
11.7.5 Ischemix Recent Development
11.8 Biomerieux
11.8.1 Biomerieux Company Details
11.8.2 Biomerieux Business Overview
11.8.3 Biomerieux Acute Kidney Injury Therapeutics Introduction
11.8.4 Biomerieux Revenue in Acute Kidney Injury Therapeutics Business (2020-2025)
11.8.5 Biomerieux Recent Development
11.9 A1M Pharma
11.9.1 A1M Pharma Company Details
11.9.2 A1M Pharma Business Overview
11.9.3 A1M Pharma Acute Kidney Injury Therapeutics Introduction
11.9.4 A1M Pharma Revenue in Acute Kidney Injury Therapeutics Business (2020-2025)
11.9.5 A1M Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Quark Pharmaceuticals
Alloksys
Angio Biomedica Corporation
Stealth Bio Therapeutics
Silver Creek Pharmaceuticals
AM Pharma Holding
Ischemix Inc
Biomerieux
A1M Pharma
List of Tables
 Table 1. Global Acute Kidney Injury Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Non-drug
 Table 3. Key Players of Drugs
 Table 4. Global Acute Kidney Injury Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Acute Kidney Injury Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Acute Kidney Injury Therapeutics Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Acute Kidney Injury Therapeutics Market Share by Region (2020-2025)
 Table 8. Global Acute Kidney Injury Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Acute Kidney Injury Therapeutics Market Share by Region (2026-2031)
 Table 10. Acute Kidney Injury Therapeutics Market Trends
 Table 11. Acute Kidney Injury Therapeutics Market Drivers
 Table 12. Acute Kidney Injury Therapeutics Market Challenges
 Table 13. Acute Kidney Injury Therapeutics Market Restraints
 Table 14. Global Acute Kidney Injury Therapeutics Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Acute Kidney Injury Therapeutics Market Share by Players (2020-2025)
 Table 16. Global Top Acute Kidney Injury Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Kidney Injury Therapeutics as of 2024)
 Table 17. Ranking of Global Top Acute Kidney Injury Therapeutics Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Acute Kidney Injury Therapeutics Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Acute Kidney Injury Therapeutics, Headquarters and Area Served
 Table 20. Global Key Players of Acute Kidney Injury Therapeutics, Product and Application
 Table 21. Global Key Players of Acute Kidney Injury Therapeutics, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Acute Kidney Injury Therapeutics Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Acute Kidney Injury Therapeutics Revenue Market Share by Type (2020-2025)
 Table 25. Global Acute Kidney Injury Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Acute Kidney Injury Therapeutics Revenue Market Share by Type (2026-2031)
 Table 27. Global Acute Kidney Injury Therapeutics Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Acute Kidney Injury Therapeutics Revenue Market Share by Application (2020-2025)
 Table 29. Global Acute Kidney Injury Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Acute Kidney Injury Therapeutics Revenue Market Share by Application (2026-2031)
 Table 31. North America Acute Kidney Injury Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Acute Kidney Injury Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Acute Kidney Injury Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Acute Kidney Injury Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Acute Kidney Injury Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Acute Kidney Injury Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Acute Kidney Injury Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Acute Kidney Injury Therapeutics Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Acute Kidney Injury Therapeutics Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Acute Kidney Injury Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Acute Kidney Injury Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Acute Kidney Injury Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Acute Kidney Injury Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Acute Kidney Injury Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Acute Kidney Injury Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Quark Pharmaceuticals Company Details
 Table 47. Quark Pharmaceuticals Business Overview
 Table 48. Quark Pharmaceuticals Acute Kidney Injury Therapeutics Product
 Table 49. Quark Pharmaceuticals Revenue in Acute Kidney Injury Therapeutics Business (2020-2025) & (US$ Million)
 Table 50. Quark Pharmaceuticals Recent Development
 Table 51. Alloksys Company Details
 Table 52. Alloksys Business Overview
 Table 53. Alloksys Acute Kidney Injury Therapeutics Product
 Table 54. Alloksys Revenue in Acute Kidney Injury Therapeutics Business (2020-2025) & (US$ Million)
 Table 55. Alloksys Recent Development
 Table 56. Angio Biomedica Corporation Company Details
 Table 57. Angio Biomedica Corporation Business Overview
 Table 58. Angio Biomedica Corporation Acute Kidney Injury Therapeutics Product
 Table 59. Angio Biomedica Corporation Revenue in Acute Kidney Injury Therapeutics Business (2020-2025) & (US$ Million)
 Table 60. Angio Biomedica Corporation Recent Development
 Table 61. Stealth Bio Therapeutics Company Details
 Table 62. Stealth Bio Therapeutics Business Overview
 Table 63. Stealth Bio Therapeutics Acute Kidney Injury Therapeutics Product
 Table 64. Stealth Bio Therapeutics Revenue in Acute Kidney Injury Therapeutics Business (2020-2025) & (US$ Million)
 Table 65. Stealth Bio Therapeutics Recent Development
 Table 66. Silver Creek Pharmaceuticals Company Details
 Table 67. Silver Creek Pharmaceuticals Business Overview
 Table 68. Silver Creek Pharmaceuticals Acute Kidney Injury Therapeutics Product
 Table 69. Silver Creek Pharmaceuticals Revenue in Acute Kidney Injury Therapeutics Business (2020-2025) & (US$ Million)
 Table 70. Silver Creek Pharmaceuticals Recent Development
 Table 71. AM Pharma Holding Company Details
 Table 72. AM Pharma Holding Business Overview
 Table 73. AM Pharma Holding Acute Kidney Injury Therapeutics Product
 Table 74. AM Pharma Holding Revenue in Acute Kidney Injury Therapeutics Business (2020-2025) & (US$ Million)
 Table 75. AM Pharma Holding Recent Development
 Table 76. Ischemix Company Details
 Table 77. Ischemix Business Overview
 Table 78. Ischemix Acute Kidney Injury Therapeutics Product
 Table 79. Ischemix Revenue in Acute Kidney Injury Therapeutics Business (2020-2025) & (US$ Million)
 Table 80. Ischemix Recent Development
 Table 81. Biomerieux Company Details
 Table 82. Biomerieux Business Overview
 Table 83. Biomerieux Acute Kidney Injury Therapeutics Product
 Table 84. Biomerieux Revenue in Acute Kidney Injury Therapeutics Business (2020-2025) & (US$ Million)
 Table 85. Biomerieux Recent Development
 Table 86. A1M Pharma Company Details
 Table 87. A1M Pharma Business Overview
 Table 88. A1M Pharma Acute Kidney Injury Therapeutics Product
 Table 89. A1M Pharma Revenue in Acute Kidney Injury Therapeutics Business (2020-2025) & (US$ Million)
 Table 90. A1M Pharma Recent Development
 Table 91. Research Programs/Design for This Report
 Table 92. Key Data Information from Secondary Sources
 Table 93. Key Data Information from Primary Sources
 Table 94. Authors List of This Report


List of Figures
 Figure 1. Acute Kidney Injury Therapeutics Picture
 Figure 2. Global Acute Kidney Injury Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Acute Kidney Injury Therapeutics Market Share by Type: 2024 VS 2031
 Figure 4. Non-drug Features
 Figure 5. Drugs Features
 Figure 6. Global Acute Kidney Injury Therapeutics Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Acute Kidney Injury Therapeutics Market Share by Application: 2024 VS 2031
 Figure 8. Hospitals Case Studies
 Figure 9. Clinic Case Studies
 Figure 10. Other Case Studies
 Figure 11. Acute Kidney Injury Therapeutics Report Years Considered
 Figure 12. Global Acute Kidney Injury Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Acute Kidney Injury Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Acute Kidney Injury Therapeutics Market Share by Region: 2024 VS 2031
 Figure 15. Global Acute Kidney Injury Therapeutics Market Share by Players in 2024
 Figure 16. Global Top Acute Kidney Injury Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Kidney Injury Therapeutics as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Acute Kidney Injury Therapeutics Revenue in 2024
 Figure 18. North America Acute Kidney Injury Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Acute Kidney Injury Therapeutics Market Share by Country (2020-2031)
 Figure 20. United States Acute Kidney Injury Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Acute Kidney Injury Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Acute Kidney Injury Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Acute Kidney Injury Therapeutics Market Share by Country (2020-2031)
 Figure 24. Germany Acute Kidney Injury Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Acute Kidney Injury Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Acute Kidney Injury Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Acute Kidney Injury Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Acute Kidney Injury Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Acute Kidney Injury Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Acute Kidney Injury Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Acute Kidney Injury Therapeutics Market Share by Region (2020-2031)
 Figure 32. China Acute Kidney Injury Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Acute Kidney Injury Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Acute Kidney Injury Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Acute Kidney Injury Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Acute Kidney Injury Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Acute Kidney Injury Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Acute Kidney Injury Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Acute Kidney Injury Therapeutics Market Share by Country (2020-2031)
 Figure 40. Mexico Acute Kidney Injury Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Acute Kidney Injury Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Acute Kidney Injury Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Acute Kidney Injury Therapeutics Market Share by Country (2020-2031)
 Figure 44. Turkey Acute Kidney Injury Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Acute Kidney Injury Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Acute Kidney Injury Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Quark Pharmaceuticals Revenue Growth Rate in Acute Kidney Injury Therapeutics Business (2020-2025)
 Figure 48. Alloksys Revenue Growth Rate in Acute Kidney Injury Therapeutics Business (2020-2025)
 Figure 49. Angio Biomedica Corporation Revenue Growth Rate in Acute Kidney Injury Therapeutics Business (2020-2025)
 Figure 50. Stealth Bio Therapeutics Revenue Growth Rate in Acute Kidney Injury Therapeutics Business (2020-2025)
 Figure 51. Silver Creek Pharmaceuticals Revenue Growth Rate in Acute Kidney Injury Therapeutics Business (2020-2025)
 Figure 52. AM Pharma Holding Revenue Growth Rate in Acute Kidney Injury Therapeutics Business (2020-2025)
 Figure 53. Ischemix Revenue Growth Rate in Acute Kidney Injury Therapeutics Business (2020-2025)
 Figure 54. Biomerieux Revenue Growth Rate in Acute Kidney Injury Therapeutics Business (2020-2025)
 Figure 55. A1M Pharma Revenue Growth Rate in Acute Kidney Injury Therapeutics Business (2020-2025)
 Figure 56. Bottom-up and Top-down Approaches for This Report
 Figure 57. Data Triangulation
 Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Acute Kidney Injury Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Acute Kidney Injury AKI Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Acute Kidney Injury Treatment Market Insights Forecast to 2030
ICU acquired Acute Kidney Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Acute Lung Injury Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
End Stage Renal Disease ESRD Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Acute Kidney Injury Treatment Management Market Insights Forecast to 2030
Global Kidney Medicine Market Insights Forecast to 2030
Acute Focal Pyelonephritis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Kidney Fibrosis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Renal Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Kidney Renal Fibrosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Renal Disease Treatment Market Research Report 2024
Global Drug induced Nephrotoxicity Treatment Market Research Report 2025
Global Chronic Kidney Disease Treatment Market Research Report 2025
Kidney Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
End Stage Renal Disease Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Acute Blood Purification Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Drugs to Treat Chronic Kidney Disease Market Research Report 2024
Rare Kidney Diseases Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Drug-Free Pain Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33I16356
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Adult Artificial Heart Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32W16534
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Viral Vector Vaccine for Humans Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-23Z16367
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Cardioplegia Adapter Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33A16598
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions